- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Double trouble: Tobacco use and Long COVID

COVID-19 brought about lasting changes that are still being felt today in the post-pandemic era, with one being the unprecedented side effect known as Long COVID.
Long COVID is characterized by symptoms affecting multiple organs and persisting for at least three months or longer after a COVID-19 infection. It has often been reported to be associated with advanced age, being female, obesity, and having other underlying conditions. However, there has not been a clear conclusion in its relation to smoking.
A research group led by graduate student Erika Toyokura, Dr. Kazuhiro Yamada, and Associate Professor Kazuhisa Asai at Osaka Metropolitan University’s Graduate School of Medicine conducted an analysis of the relationship between Long COVID and tobacco use. They classified participants into five categories, non-smokers, former users, combustible cigarette (CC) users, heated tobacco product (HTP) users, and dual users, based on data from the JASTIS 2023, a nationwide internet survey involving 34,000 participants, with 28,250 included in the analysis and 5,068 with a history of COVID-19.
The analysis results revealed that current smokers were more associated with four symptoms, arthralgia, chest pain, dyspnea, and dysosmia, than non-smokers. In dual users, five symptoms, arthralgia, chest pain, dyspnea, dysgeusia, and dysosmia, were common. CC users correlated with three symptoms, chest pain, dyspnea, and dysosmia, while HTP users suffered from symptoms of dyspnea and sexual dysfunction.
Further, Long COVID symptoms may also be affected differently depending on the type and habits of smoking. It is suggested that the added concurrent use of combustible and heated tobacco products may worsen symptoms.
“This study is the first to reveal that Long COVID differs depending on smoking patterns. Specifically, individuals who use both combustible and heated tobacco products showed a stronger correlation with more symptoms. These findings underscore the importance of ceasing tobacco use,” Toyokura stated. Professor Asai concluded, “Going forward, we plan to examine the causal relationship and underlying mechanisms between smoking and Long COVID symptoms, and apply these findings to public health policies and clinical practice.”
Reference:
Toyokura, E., Yamada, K., Asai, K. et al. Dual use of combustible and heated tobacco products associates persistent symptoms with a history of COVID-19: a JASTIS 2023 cross‑sectional study. Sci Rep 15, 38659 (2025). https://doi.org/10.1038/s41598-025-22050-x
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

